Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Sabrina Kuespert"'
Autor:
Andrea E. Dillinger, Sabrina Kuespert, Amin A. Seleem, Jakob Neuendorf, Magdalena Schneider, Rudolf Fuchshofer
Publikováno v:
Frontiers in Molecular Biosciences, Vol 10 (2023)
TGF-β2 is the predominant TGF-β isoform within the eye. One function of TGF-β2 is to provide the eye with immune protection against intraocular inflammation. The beneficial function of TGF-β2 within the eye must be under tight control of a networ
Externí odkaz:
https://doaj.org/article/0194ad2ada9643be9734e61da67451ca
Autor:
Sebastian Peters, Eva Wirkert, Sabrina Kuespert, Rosmarie Heydn, Sven Korte, Lars Mecklenburg, Ludwig Aigner, Siw Johannesen, Tim-Henrik Bruun, Ulrich Bogdahn
Publikováno v:
Applied Sciences, Vol 12, Iss 3, p 973 (2022)
Increasingly antisense oligonucleotides (ASOs) are developed for potential treatment of CNS disorders, and due to the inability to cross the blood brain barrier, they require direct administration into the cerebrospinal fluid (CSF). In this regard, i
Externí odkaz:
https://doaj.org/article/4027f861493a47a29d8001e8f86f1eb9
Autor:
Sebastian Peters, Eva Wirkert, Sabrina Kuespert, Rosmarie Heydn, Siw Johannesen, Anita Friedrich, Susanne Mailänder, Sven Korte, Lars Mecklenburg, Ludwig Aigner, Tim-Henrik Bruun, Ulrich Bogdahn
Publikováno v:
Pharmaceutics, Vol 14, Iss 1, p 200 (2022)
The capability of the adult central nervous system to self-repair/regenerate was demonstrated repeatedly throughout the last decades but remains in debate. Reduced neurogenic niche activity paralleled by a profound neuronal loss represents fundamenta
Externí odkaz:
https://doaj.org/article/2be091cb44884b99a0ace5ee62d10f3a
Autor:
Sabrina Kuespert, Rosmarie Heydn, Sebastian Peters, Eva Wirkert, Anne-Louise Meyer, Mareile Siebörger, Siw Johannesen, Ludwig Aigner, Ulrich Bogdahn, Tim-Henrik Bruun
Publikováno v:
International Journal of Molecular Sciences, Vol 21, Iss 6, p 1952 (2020)
Antisense Oligonucleotides (ASOs) are an emerging drug class in gene modification. In our study we developed a safe, stable, and effective ASO drug candidate in locked nucleic acid (LNA)-gapmer design, targeting TGFβ receptor II (TGFBR2) mRNA. Disco
Externí odkaz:
https://doaj.org/article/7b458612d8254c0e8aebceb9b9f7159e
Autor:
Sebastian Peters, Eva Zitzelsperger, Sabrina Kuespert, Sabine Iberl, Rosmarie Heydn, Siw Johannesen, Susanne Petri, Ludwig Aigner, Dietmar R. Thal, Andreas Hermann, Jochen H. Weishaupt, Tim-Henrik Bruun, Ulrich Bogdahn
Publikováno v:
Frontiers in Neurology, Vol 8 (2017)
Amyotrophic lateral sclerosis (ALS) represents a fatal orphan disease with high unmet medical need, and a life time risk of approx. 1/400 persons per population. Based on increasing knowledge on pathophysiology including genetic and molecular changes
Externí odkaz:
https://doaj.org/article/d058721d2002498e98efced3074ddb08
Autor:
Sven Korte, Benjamin Jurek, Dietmar Rudolf Thal, Florian Timo Ludwig, Sebastian A. Lewandowski, Tim-Henrik Bruun, Rosmarie Heydn, Inci Sevval Aksoylu, Joachim Weis, Andreas Hermann, Eva Wirkert, Heike Mrowetz, Barbara Altendorfer, Rodolphe Poupardin, Lars Mecklenburg, Sebastian Peters, Ohnmar Hsam, Siw Johannesen, Ulrich Bogdahn, Ludwig Aigner, Susanne Petri, Jochen H. Weishaupt, Sabrina Kuespert
Publikováno v:
Neurotherapeutics 18(3), 1963-1979 (2021). doi:10.1007/s13311-021-01045-2
Neurotherapeutics
Neurotherapeutics : official journal of the American Society for Experimental NeuroTherapeutics (ASENT) 18(3), 1963-1979 (2021). doi:10.1007/s13311-021-01045-2
Neurotherapeutics
Neurotherapeutics : official journal of the American Society for Experimental NeuroTherapeutics (ASENT) 18(3), 1963-1979 (2021). doi:10.1007/s13311-021-01045-2
Neurotherapeutics : official journal of the American Society for Experimental NeuroTherapeutics (ASENT) 18(3), 1963-1979 (2021). doi:10.1007/s13311-021-01045-2
Published by Springer, New York, NY
Published by Springer, New York, NY
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a720507a761d33ae4f93f9fa50bdf546
Publikováno v:
Cell and Tissue Research
CCN2/CTGF is a matricellular protein that is known to enhance transforming growth factor-β signaling and to induce a myofibroblast-like phenotype in a variety of cell types. Here, we investigated Ccn2/Ctgf promotor activity during development and in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::132915c2840e8c8aab5bd2f6c0aefda4
Autor:
Andrea E. Dillinger, Renato V. Iozzo, Magdalena Schneider, Rudolf Fuchshofer, Gregor R Weber, Andreas Ohlmann, Ernst R. Tamm, Harry A. Quigley, Ramona Pawlak, Sabrina Kuespert
Publikováno v:
Matrix biology : journal of the International Society for Matrix Biology. 97
Primary open-angle glaucoma a neurodegenerative disorder characterized by degeneration of optic nerve axons, is a frequent cause of vision loss and blindness worldwide. Several randomized multicenter studies have identified intraocular pressure as th
Autor:
Ulrich Bogdahn, Tim-Henrik Bruun, Rosmarie Heydn, Eva Wirkert, Siw Johannesen, Mareile Siebörger, Sabrina Kuespert, Sebastian Peters, Ludwig Aigner, Anne-Louise Meyer
Publikováno v:
International Journal of Molecular Sciences
International Journal of Molecular Sciences, Vol 21, Iss 6, p 1952 (2020)
Volume 21
Issue 6
International Journal of Molecular Sciences, Vol 21, Iss 6, p 1952 (2020)
Volume 21
Issue 6
Antisense Oligonucleotides (ASOs) are an emerging drug class in gene modification. In our study we developed a safe, stable, and effective ASO drug candidate in locked nucleic acid (LNA)-gapmer design, targeting TGF&beta
receptor II (TGFBR2) mRN
receptor II (TGFBR2) mRN
Publikováno v:
Journal of Drug Targeting. 24:952-959
The major risk factor for primary open-angle glaucoma is increased intraocular pressure stemming from elevated outflow resistance in the trabecular meshwork (TM) region. Integrins play a pivotal role in the TM by influencing its biological properties